Peter Ellis, 69, from Manchester tells us about his experience finding out he had prostate cancer after an unlucky golf ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

Artificial intelligence (AI)-based risk classification improves prognostication with localized prostate cancer, according to ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...